BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33389860)

  • 1. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
    Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
    Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Biomarkers in Colorectal Cancer.
    Verma M; Kumar V
    Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Coppedè F; Lopomo A; Spisni R; Migliore L
    World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and chromatin modifiers in colorectal cancer.
    Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
    Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance.
    Zhao N; Lai C; Wang Y; Dai S; Gu H
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189096. PubMed ID: 38499079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic therapy for colorectal cancer.
    Vaish V; Khare T; Verma M; Khare S
    Methods Mol Biol; 2015; 1238():771-82. PubMed ID: 25421691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
    Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
    Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
    Ray SK; Mukherjee S
    Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
    Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
    Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Drug Therapy in the Treatment of Colorectal Cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Seifi S; Parizadeh SMR; Moetamani-Ahmadi M; Hassanian SM; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Pharm Des; 2018; 24(23):2701-2709. PubMed ID: 30062956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
    Cao Q; Tian Y; Deng Z; Yang F; Chen E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
    Postwala H; Shah Y; Parekh PS; Chorawala MR
    Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
    Coppedè F
    Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.